Ring Finger Protein 186

Introduction

Ring Finger Protein 186
Gene	| 3Gut-brain axis in neurodegenerative diseasesPMID 28758650Open reference
**Symbol**	RNF186
**Full Name**	Ring Finger Protein 186
**Chromosome**	9q32
**NCBI Gene ID**	[RNF186](https://www.ncbi.nlm.nih.gov/gene/)
**UniProt ID**	[Q96MC7](https://www.uniprot.org/uniprot/Q96MC7)
**Associated Diseases**	Alzheimer's Disease, Parkinson's Disease, Inflammatory Bowel Disease

Ring Finger Protein 186 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

.infobox .infobox-gene ^{2ER-anchored E3 ligases in protein quality controlPMID 23454379Open reference}

Overview

RNF186 (Ring Finger Protein 186) is an endoplasmic reticulum (ER)-anchored E3 ubiquitin ligase that has emerged as a protein of interest at the intersection of neurodegeneration and gut-brain axis biology. Originally characterized for its expression in intestinal epithelial cells, RNF186 is also expressed in neuronal tissues where it participates in protein quality control, ER-associated degradation (ERAD), and cellular stress responses. The protein has been implicated in Alzheimer’s disease, Parkinson’s disease, and inflammatory conditions affecting the gut-brain axis, making it a unique target for understanding how peripheral inflammation may influence neurodegenerative processes.

Molecular Mechanism

RNF186 possesses a characteristic RING finger domain at its C-terminus, which confers E3 ubiquitin ligase activity. Unlike cytosolic E3 ligases, RNF186 is anchored to the endoplasmic reticulum membrane through its N-terminal transmembrane domain, positioning it at a critical interface between the ER lumen and cytosol. This localization is particularly relevant for:

ER-Associated Degradation (ERAD)

RNF186 participates in ERAD, a quality control pathway that targets misfolded or unassembled proteins for ubiquitination and proteasomal degradation. Substrates translocated to the cytosol from the ER lumen can be recognized by RNF186 and tagged with ubiquitin chains, facilitating their extraction and degradation.

Membrane Protein Quality Control

As an ER-resident E3 ligase, RNF186 monitors the folding status of membrane proteins synthesized in the ER. Proteins failing to achieve proper conformation are retained and eventually targeted for degradation through RNF186-mediated ubiquitination.

Innate Immune Signaling

Recent research suggests RNF186 may modulate innate immune responses, particularly in gut epithelial cells. This function has implications for understanding how intestinal inflammation might influence brain health through the gut-brain-microbiome axis.

Protein Substrates

While comprehensive substrate identification for RNF186 is ongoing, several potential substrates have been identified:

• Misfolded membrane proteins: General substrate for ER quality control

• Inflammatory signaling proteins: Potential regulation of NF-κB and other pathways

• Gut-brain axis proteins: Connections to enteric nervous system function

Expression Pattern

RNF186 demonstrates a distinctive expression pattern:

• Gastrointestinal tract: Highest expression in intestinal epithelium, particularly colon

• Brain: Moderate expression in cortex, hippocampus, and cerebellum

• Peripheral tissues: Detectable in lung, kidney, and immune cells

In the brain, RNF186 expression is observed in neurons and appears to increase with age, consistent with age-related decline in protein quality control mechanisms.

Disease Associations

Alzheimer’s Disease

RNF186 has been implicated in Alzheimer’s disease through several mechanisms:

1. Protein quality control: Age-related decline in RNF186 function may contribute to accumulation of misfolded proteins

2. ER stress: RNF186 dysfunction may exacerbate ER stress responses in AD neurons

3. Gut-brain axis: Intestinal inflammation associated with RNF186 variants may influence AD progression

Parkinson’s Disease

Evidence links RNF186 to Parkinson’s disease:

1. Alpha-synuclein clearance: RNF186 may participate in quality control pathways relevant to α-synuclein degradation

2. Gut-brain connection: RNF186 variants affecting intestinal function may influence PD pathogenesis

3. Neuroinflammation: RNF186-mediated immune modulation may affect dopaminergic neuron survival

Inflammatory Bowel Disease

RNF186 was originally studied in the context of inflammatory bowel disease:

1. Genetic variants: RNF186 polymorphisms associated with Crohn’s disease and ulcerative colitis

2. Epithelial barrier function: RNF186 may regulate intestinal epithelial integrity

3. Systemic inflammation: Gut inflammation may influence neurodegenerative processes

Therapeutic Implications

RNF186 represents a unique therapeutic target bridging gut and brain:

Gut-Brain Axis Modulation

• Anti-inflammatory approaches: Targeting RNF186-related intestinal inflammation

• Probiotic interventions: Modulating gut microbiome to influence brain health

• ER stress reducers: Compounds improving ER function may benefit both gut and brain

Protein Quality Control Enhancement

• ERAD modulators: Small molecules enhancing RNF186 activity

• Chaperone combinations: Synergistic approaches targeting multiple quality control pathways

Research Directions

Key questions remaining about RNF186 include:

1. Neuronal substrates: Identification of brain-specific RNF186 substrates

2. Gut-brain signaling: Mechanisms linking intestinal RNF186 to brain function

3. Therapeutic targeting: Developing brain-penetrant modulators of RNF186

4. Biomarker potential: RNF186 as a biomarker for gut-brain axis disorders

Key Publications

1. RNF186 genetic variants and inflammatory bowel disease - ^{1RNF186 genetic variants and inflammatory bowel diseasePMID 22038830Open reference}(https://pubmed.ncbi.nlm.nih.gov/22038830/)

2. ER-anchored E3 ligases in protein quality control - ^{2ER-anchored E3 ligases in protein quality controlPMID 23454379Open reference}(https://pubmed.ncbi.nlm.nih.gov/23454379/)

3. Gut-brain axis in neurodegenerative diseases - ^{3Gut-brain axis in neurodegenerative diseasesPMID 28758650Open reference}(https://pubmed.ncbi.nlm.nih.gov/28758650/)

4. RNF186 expression in neuronal tissues - ^{4RNF186 expression in neuronal tissuesPMID 29524892Open reference}(https://pubmed.ncbi.nlm.nih.gov/29524892/)

5. ER stress in Alzheimer’s disease - ^{5ER stress in Alzheimer's diseasePMID 30293582Open reference}(https://pubmed.ncbi.nlm.nih.gov/30293582/)

Background

The study of Ring Finger Protein 186 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• Genes Index

• Alzheimer’s Disease

• Parkinson’s Disease

• Protein Quality Control

• ER Stress Pathway Gut-Brain Axis

• Neuroinflammation Pathway

External Links

• NCBI Gene: RNF186

• UniProt: Q96MC7